Detalhe da pesquisa
1.
A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
Diabetes Obes Metab
; 25(11): 3400-3409, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580967
2.
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes.
Diabetes Metab Res Rev
; 38(3): e3500, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611978
3.
Combined Etanercept, GAD-alum and vitamin D treatment: an open pilot trial to preserve beta cell function in recent onset type 1 diabetes.
Diabetes Metab Res Rev
; 37(7): e3440, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486892
4.
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
Diabetes Metab Res Rev
; 35(4): e3132, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30693639
5.
Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
Diabetologia
; 61(6): 1484-1490, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29532109
6.
Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response.
Diabetologia
; 60(7): 1276-1283, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28357504
7.
GAD-specific T cells are induced by GAD-alum treatment in Type-1 diabetes patients.
Clin Immunol
; 176: 114-121, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131926
8.
Characteristics of the pre-diabetic period in children with high risk of type 1 diabetes recruited from the general Swedish population-The ABIS study.
Diabetes Metab Res Rev
; 33(6)2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28371132
9.
Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
N Engl J Med
; 376(7): 697-699, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199812
10.
More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
N Engl J Med
; 377(4): 403-5, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28745988
11.
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
N Engl J Med
; 366(5): 433-42, 2012 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22296077
12.
GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months.
Diabetes Metab Res Rev
; 30(5): 405-14, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24302596
13.
Low C-peptide levels and decreased expression of TNF and CD45 in children with high risk of type 1 diabetes.
Clin Immunol
; 148(1): 4-15, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23644451
14.
Regulatory T-Cell Phenotyping Using CyTOF.
Methods Mol Biol
; 2559: 231-242, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180636
15.
Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype.
Front Immunol
; 14: 1112570, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36817467
16.
GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.
Pediatr Diabetes
; 13(3): 244-50, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21848927
17.
Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes.
BMJ Open Diabetes Res Care
; 10(6)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351678
18.
Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial).
Acta Diabetol
; 59(5): 687-696, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098372
19.
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol.
BMJ Open
; 12(10): e061776, 2022 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316084
20.
Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.
J Clin Endocrinol Metab
; 107(9): 2644-2651, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665810